SFGP
GILD icon

Stonebridge Financial Group (Pennsylvania)’s Gilead Sciences GILD Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,880
Closed -$323K – 492
2025
Q1 		$323K Buy
2,880
+2,288
+386% +$236K 0.03% 176
2024
Q4 		$54.7K Buy
+592
New +$53.3K 0.01% 366

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s GILD Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 2,880 shares — an estimated $323K sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in GILD in Q4 2024 and held it in 2 quarters. The position peaked at $323K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 2,880 Gilead Sciences shares in Q2 2025, an estimated $323K.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Gilead Sciences in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s Gilead Sciences position peaked at $323K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.